MedTrace Logo

Safety and Efficacy of Stem Cell Therapy in Spinal Cord Injury

NCT02027246 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-10-25

No results posted yet for this study

Summary

The aim of this study was to study the effect of stem cell therapy on common symptoms of spinal cord injury patients.

Conditions

  • Spinal Cord Injury

Interventions

BIOLOGICAL

Autologous bone marrow mononuclear cell transplantation

Bone marrow is aspirated by a standard procedure. Mononuclear cells are separated by density gradient method and then injected intrathecally by a standard lumbar puncture procedure

Sponsors & Collaborators

  • Neurogen Brain and Spine Institute

    lead OTHER

Principal Investigators

  • Alok K Sharma, M.S., M.Ch · Neurogen Brain and Spine Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Months
Max Age
63 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-08-31
Completion
2013-02-28

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027246 on ClinicalTrials.gov